20 results

• California Judge Grants Defense Verdict For Drug Manufacturers In Opioid Crisis Lawsuit

  November 3, 2021

  Irvin Jackson

  Johnson & Johnson, Teva and other drug manufacturers won a bench decision in an opioid crisis trial in California, after the judge ruled there was no evidence linking the companies' actions to the ongoing drug pandemic.

• Generic Chantix Launched Following Recall of Name Brand Drug Due To Toxic Contaminant

  September 27, 2021

  Irvin Jackson

  The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.

• Testosterone Drug Settlement Resolves Over 1,300 Testim Heart Attack, Stroke Cases

  June 14, 2018

  Irvin Jackson

  Endo International has finalized a Testim testosterone gel settlement agreement which will resolve about 1,300 lawsuits over heart attack and stroke injury claims.

• Testim Settlements May Resolve More Than 1,300 Lawsuits Over Testosterone Gel

  February 26, 2018

  Austin Kirk

  A proposed settlement could resolve all testosterone lawsuits filed by users of Testim, claiming to have suffered heart attacks, strokes and other side effects.

• Opana ER Addiction Lawsuit Filed By Kentucky

  November 9, 2017

  Irvin Jackson

  An Opana ER lawsuit filed by Kentucky claims that Endo Pharmaceutical illegally marketed a dangerous drug that resulted in 191 deaths last year.

• Testim Gel Heart Attack Lawsuit Cleared for Trial to Proceed November 6

  October 25, 2017

  Austin Kirk

  The first bellwether trial involving claims that the side effects of Testim, the testosterone gel, caused a man's heart attack has survived a summary judgment effort by Auxilium and will proceed to trial on November 6, according to a court order.

• Vaginal Mesh Settlements Top $2.6B in Payments by Endo to Resolve All Lawsuits

  August 9, 2017

  Irvin Jackson

  Endo Pharmaceuticals plans to pay nearly $800 million to resolve thousands of remaining vaginal mesh lawsuits.

• Doctors Need To Be Educated About Opioid Risks, FDA Chief Says At Conference

  July 11, 2017

  Martha Garcia

  The FDA will soon roll out new education requirements for doctors prescribing opioid painkillers, in the face of an ongoing national drug abuse epidemic.

• Opana ER Recall Urged by FDA, Due to Opioid Abuse Risk

  June 9, 2017

  Irvin Jackson

  The FDA is calling for an Opana ER recall after determining that the risk of abuse outweighs any benefits, linking the drug to outbreaks of HIV and hepatitis C.

• Opana ER Risks Outweigh Benefits, Despite “Abuse-Deterrant” Claims: FDA Panel

  March 15, 2017

  Martha Garcia

  A panel of FDA advisers is calling for an Opana ER recall, saying the drug's risks outweigh the benefits after abusers found a way to defeat its "abuse-deterrent" design by injecting it.